1. Home
  2. ZURA vs CBK Comparison

ZURA vs CBK Comparison

Compare ZURA & CBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zura Bio Limited

ZURA

Zura Bio Limited

HOLD

Current Price

$6.18

Market Cap

455.4M

Sector

Health Care

ML Signal

HOLD

Logo Commercial Bancgroup Inc.

CBK

Commercial Bancgroup Inc.

HOLD

Current Price

$34.39

Market Cap

476.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ZURA
CBK
Founded
2022
1975
Country
United States
United States
Employees
N/A
298
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
455.4M
476.8M
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
ZURA
CBK
Price
$6.18
$34.39
Analyst Decision
Buy
Analyst Count
6
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
1.5M
31.2K
Earning Date
05-14-2026
04-27-2026
Dividend Yield
N/A
1.40%
EPS Growth
N/A
16.14
EPS
N/A
0.70
Revenue
N/A
N/A
Revenue This Year
N/A
$11.67
Revenue Next Year
N/A
$8.05
P/E Ratio
N/A
$49.71
Revenue Growth
N/A
N/A
52 Week Low
$1.88
$23.24
52 Week High
$7.25
$35.78

Technical Indicators

Market Signals
Indicator
ZURA
CBK
Relative Strength Index (RSI) 60.07 52.00
Support Level $5.22 $33.33
Resistance Level $6.76 $34.46
Average True Range (ATR) 0.41 0.77
MACD -0.00 -0.02
Stochastic Oscillator 47.98 53.32

Price Performance

Historical Comparison
ZURA
CBK

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

About CBK Commercial Bancgroup Inc.

Commercial Bancgroup Inc is a bank holding company. Through its subsidiary, it operates as a full-service community banking institution offering traditional consumer and commercial products and services to businesses and individuals in select markets in Kentucky, North Carolina, and Tennessee. In Tennessee, its service areas include the metropolitan statistical areas of Nashville Davidson, Murfreesboro, Franklin, Knoxville, and the Tri Cities region of Kingsport, Bristol, and Johnson City, as well as Claiborne County, Cocke County, Union County, Hamblen County, and their surrounding areas.

Share on Social Networks: